Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
N/A
Prevotella species are anaerobic Gram_negative bacteria of the Bacteroidetes phylum, which also includes the clinically important genera Bacteroides and Porphyromonas. Prevotella strains are classically considered commensal bacteria due to their extensive presence in the healthy human body and their rare involvement in infections. Only a few strains have been reported to give rise to opportunistic endogenous infections, including chronic infections, abscesses and anaerobic pneumonia. Emerging studies in humans have linked the increased abundance of Prevotella species at mucosal sites to localized and systemic disease, including periodontitis, bacterial vaginosis, rheumatoid arthritis, metabolic disorders and low_grade systemic inflammation. Intriguingly, Prevotella abundance is reduced within the lung microbiota of patients with asthma and chronic obstructive pulmonary disease. Increased Prevotella abundance is associated with augmented T helper type 17 (Th17) _mediated mucosal inflammation, which is in line with the marked capacity of Prevotella in driving Th17 immune responses in vitro. [PMID: 28542929]
Prevotella dentalis DSM 3688 (formerly Mitsuokella dentalis), a human oral bacterium often associated with root canal infections was isolated from a human dental root canal. They are singly-occurring Gram-negative, obligately anaerobic, non-spore-forming, nonmotile, blunt-ended, oval rods that measure 0.7 by 1.0 to 2 um. Peritrichous fimbrae and a thick capsulelike structure are present. It is the type strain (adapted from PMID 7547307). In addition to the fully sequenced genome there is another wgs project which is a reference genome for the Human Microbiome Project. [UP000010862]
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces and dental disease
DNA G+C(%): 56-60
|
Bile reaction(%): 20(neg)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
Augmentin: S(MIC50): 0.125, MIC90: 1, RNG: (≤0.015-1)
penicillin_G: Var(MIC50): 0.125, MIC90: >32, RNG: (≤0.03->32)
|
cefalexin: Var(MIC50): 2, MIC90: >32, RNG: (0.06->32)
|
|
azithromycin: S(MIC50): 0.125, MIC90: 1, RNG: (0.06->32)
erythromycin: S(MIC50): 0.125, MIC90: 0.5, RNG: (≤0.03->32)
|
ciprofloxacin: S(MIC50): 1, MIC90: 4, RNG: (≤0.5->8)
levofloxacin: S(MIC50): 0.5, MIC90: 2, RNG: (≤0.06->8)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
tetracycline: R(MIC50): 8, MIC90: 32, RNG: (0.125->32)
|
|
|
metronidazole: S(MIC50): 0.5, MIC90: 1, RNG: (0.06-2)
|
clindamycin: S(MIC50): ≤0.03, MIC90: ≤0.03, RNG: (≤0.03->32)
|